Skip to main content
05_Bernardo_Franklin
© Photo: Bruna Guerra Photography

News categories: Honors & Funding

ERC Proof of Concept Grants for UNBIAS

European Research Council is supporting the journey from basic research to application

Prof. Bernardo Franklin from the Institute of Innate Immunity at the University Hospital Bonn has been awarded a Proof of Concept Grant by the European Research Council (ERC) as part of a program designed to help researchers translate their ideas from previous ERC projects into commercial applications. The project is awarded with a funding of €150,000, provided over a period of around one year.

ImmunoSensation2 member Prof. Dr. Bernardo S. Franklin studies hematopoietic stem cells (HSCs), which develop into different blood cells through processes of cell division and differentiation. “Bouts of inflammation that a person experiences as they get older will damage these stem cells,“ Bernardo S. Franklin says. “Processes like this cause hyperactivation of the innate immune system in the elderly.” This phenomenon, known as “inflammaging,” increases the risk of conditions including cardiovascular disease, diabetes and cancer, he adds.

“Wiping” the immune system’s harmful memories of inflammation


The project that has now secured ERC funding, which is entitled “Nanobodies to prevent hematopoietic stem cell bias and hyper-inflammation” (UNBIAS), aims to return HSCs to their original state in order to “wipe” the immune system’s harmful memories of inflammation. The researchers are using customized “mini-antibodies” known as nanobodies to achieve this. These antibodies, which are very small in relative terms, are taken from the blood of alpacas and can break up the places where inflammation develops.

Back in 2017, Franklin received a much-sought-after Starting Grant from the ERC worth some €1.5 million in funding. The Proof of Concept Grant will now build on this work already done. “Our aim is to validate the use of nanobodies to combat inflammaging and license this technology or its applications for industrial partners,” Franklin says. He believes that the project has the potential to alleviate the effects of inflammation and thus potentially save countless lives and the economic cost of illness.

Contact

Prof. Dr. Bernardo S. Franklin

Institute for Innate Immunity

University Hospital Bonn

Phone +49 228 28751981

Email: franklin@uni-bonn.de

Related news

Bone2Gene Funding Peter Krawitz

News categories: Honors & Funding

“Bone2Gene” Secures €1 Million Grant

The “Bone2Gene” project of researchers from the University of Bonn and University Hospital Bonn has been awarded funding worth €1,000,000 as part of the Federal Ministry of Education and Research’s GO-Bio initial program. The money is now enabling the team arround ImmunoSensation Member Prof. Peter Krawitz, to progress to the feasibility phase and get its product ready for market launch. “Bone2Gene“ is using artificial intelligence (AI) to make genetic bone conditions known as skeletal dysplasia easier to spot and diagnose.
View entry
W1 female immunity

News categories: Honors & Funding

New junior professorship for female immunity in Bonn

Anchoring gender perspectives in research: with this aim in mind, the Ministry of Culture and Science of the state of North Rhine-Westphalia is promoting gender denomination for professorships. The University of Excellence Bonn is now receiving a new junior professorship for female immunity at the Faculty of Medicine from the programme. The junior professorship is intended to expand the research focus on immunology at the University of Bonn and the University Hospital Bonn (UKB) to include important issues relating to gender and gender-specific aspects in immunology and women's health.
View entry
Elvira Mass MagNet: Macrophage Niche Network Dynamics

News categories: Honors & Funding

The ‘choreographers’ of tissue development and function

The German Research Foundation (DFG) is setting up a new research group at the University of Bonn. ‘MagNet: Macrophage Niche Network Dynamics’ is dedicated to the systematic study of macrophages, specialised immune cells that play a central role in tissue development and function. The spokesperson of the research group is ImmunoSensation member Prof Dr Elvira Mass from the University of Bonn, supported by co-spokesperson Prof Dr Falk Nimmerjahn from Friedrich-Alexander-Universität Erlangen-Nürnberg (FAU).
View entry

Back to the news overview